Summary: Randomized controlled trial (the DIABEGG study), n=140 overweight/obese adults with prediabetes or type 2 diabetes in Sydney, Australia, randomized to a high-egg diet (2 eggs/day, 6 days/week) or a low-egg diet (<2 eggs/week) for 3 months during weight maintenance. No significant between-group differences emerged in LDL-C, HDL-C, total cholesterol, or triglycerides; the high-egg group reported greater satiety. Outcome is a surrogate lipid endpoint, not clinical events.
Relevance: Direct RCT evidence that ~2 eggs/day does not worsen blood lipids in a type-2-diabetic/prediabetic population — the core pro-egg “DIABEGG shows 2 eggs/day is safe in T2D” heterogeneity finding named in the brief.